Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Non-randomized Single-arm Trial of Efferent Neuromodulation Immune and Gastrointestinal Systems by VNS in the Epilepsy Population

NCT03953768 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.

NCT NCT03953768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03953768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Non-randomized Single-arm Trial of Efferent Neuromodulation Immune and Gastrointestinal Systems by VNS in the Epilepsy Population
Lead sponsor
University of Louisville
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2021
Completion date
December 31, 2026
Enrollment
30 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, autonomic dysfunction, epilepsy, inflammatory bowel diseases